Edition:
United States

Becton Dickinson and Co (BDX)

BDX on New York Consolidated

221.50USD
20 Nov 2017
Change (% chg)

$1.19 (+0.54%)
Prev Close
$220.31
Open
$221.15
Day's High
$222.31
Day's Low
$220.48
Volume
807,948
Avg. Vol
1,180,119
52-wk High
$225.23
52-wk Low
$161.29

Latest Key Developments (Source: Significant Developments)

BD board increases dividend
Monday, 20 Nov 2017 04:30pm EST 

Nov 20 (Reuters) - Becton Dickinson And Co ::BD board increases dividend.Becton Dickinson And Co - ‍declared a quarterly dividend of $0.75 per common share, an increase of 2.7 percent from previous quarter​.  Full Article

Merit Medical signs purchase agreement with BD for divestment assets
Thursday, 16 Nov 2017 06:30am EST 

Nov 16 (Reuters) - Merit Medical Systems Inc ::Merit Medical signs purchase agreement with BD for divestment assets.Merit Medical Systems Inc - ‍purchase price for product lines and related assets to be acquired is $100 million​.Merit Medical Systems Inc - ‍purchase price for product lines and related assets to be acquired is $100 million​.Merit Medical Systems- ‍intends to finance acquisition at closing through borrowings which are currently available under its revolving credit facility​.Merit Medical Systems Inc - ‍transaction is also expected to expand operating margins and increase cash flow​.Merit - ‍has signed asset purchase agreement with bd to acquire certain assets which bd proposes to sell in connection with acquisition of C.R. Bard​.Merit Medical Systems Inc - ‍transaction is expected to be accretive to both GAAP and non-GAAP earnings in 2018 for Merit's shareholders​.Merit Medical Systems Inc - ‍expects acquisition to provide $0.10-$0.19 in adjusted non-GAAP earnings per share accretion in fiscal year 2018​.Merit Medical Systems Inc - ‍ expects deal to be accretive by 50-120 basis points to co's adjusted gross margins over a period of six to twelve months​.  Full Article

Becton Dickinson says Q4 earnings per share $1.24
Thursday, 2 Nov 2017 06:00am EDT 

Nov 2 (Reuters) - Becton Dickinson And Co -:BD announces results for 2017 fourth fiscal quarter and full year; provides fiscal 2018 guidance.Q4 earnings per share $1.24.Q4 revenue $3.166 billion versus I/B/E/S view $3.15 billion.Q4 earnings per share view $2.37 -- Thomson Reuters I/B/E/S.Q4 adjusted earnings per share $2.40.Sees FY 2018 earnings per share $10.55 to $10.65 including items.Sees FY 2018 revenue $12.09 billion.Becton Dickinson And Co - ‍acquisition of C.R. Bard is on-track with an expected closing date in fourth calendar quarter of 2017​.Becton Dickinson-‍on stand-alone basis, co expects FY 2018 revenues to increase 5.0 to 6.0 percent as reported, or 4.0 to 5.0 percent on currency-neutral basis​.  Full Article

U.S. court denies motion to reconsider Becton, Dickinson and Co. judgment
Tuesday, 31 Oct 2017 02:27pm EDT 

Oct 31 (Reuters) - Retractable Technologies Inc ::Retractable Technologies Inc says on Oct 27, court denied motion to alter or amend earlier judgment in co's case against Becton, Dickinson and Co​.  Full Article

BD statement on European Commission conditional clearance of Bard acquisition
Wednesday, 18 Oct 2017 10:17am EDT 

Oct 18 (Reuters) - Becton Dickinson and Co :BD statement on European Commission conditional clearance of bard acquisition.Says continue to expect that BD and Bard transaction will close in fourth calendar quarter of 2017​.Says ‍"committed" to divesting certain assets to satisfy conditions requested by European Commission​ for Bard deal.  Full Article

Becton Dickinson and Co announces launch of platform for RNA expression analysis
Tuesday, 12 Sep 2017 07:00am EDT 

Sept 12 (Reuters) - Becton Dickinson and Co ::Becton Dickinson and Co - announces launch of BD rhapsody, a platform for RNA expression analysis.Becton Dickinson and Co - ‍bd rhapsody platform assay offering will be rapidly expanded over next 12 months​.Becton Dickinson and Co - has initiated early access for abseq protein detection on BD rhapsody system, expects commercial availability in H1 2018.Becton Dickinson and Co - ‍ BD rhapsody platform is also being expanded beyond RNA expression to include protein detection​.  Full Article

BD announces extension of exchange offers and consent solicitations for C. R. Bard Inc notes
Tuesday, 29 Aug 2017 06:30am EDT 

Aug 29 (Reuters) - Becton Dickinson And Co :BD announces extension of exchange offers and consent solicitations for C. R. Bard Inc notes.Becton Dickinson And Co - amended exchange offers and consent solicitations to extend expiration date to 12:01 a.m., New York City time, Sept 27, 2017.  Full Article

Retractable Technologies says court dismissed co's case against Becton, Dickinson and Co​
Friday, 18 Aug 2017 03:28pm EDT 

Aug 18 (Reuters) - Retractable Technologies Inc ::On August 17, judge issued court's final judgment regarding RTI's suit against Becton, Dickinson and Co​.Judgment orders that RTI take nothing in its suit against BD and dismisses case​.Considering its options, including motion for new trial or to amend judgment, appeal to fifth circuit court of appeals​.  Full Article

FDA provides update on its investigation into inaccurate results from certain lead tests‍​
Thursday, 17 Aug 2017 06:03pm EDT 

Aug 17 (Reuters) - U.S. Food and Drug Administration-:U.S. FDA provides update on its investigation into inaccurate results from certain lead tests‍​.U.S. FDA - conducted an inspection of Becton Dickinson & Company, the manufacturer of certain blood collection tubes used alongside these tests‍​.‍U.S. FDA-Report issued at conclusion of inspection of BD’s Franklin Lakes, New Jersey facility includes observations that may be violations of federal law​.u.s. fda - at this time, not determined that Becton Dickinson tubes,any other brand of tube linked to cause of the inaccurate lead test results‍​.U.S. FDA-Reviewing evidence collected from inspection of BD’s facility to decide if there were violations of federal law & if further action is warranted.FDA-Conducted inspection of becton dickinson‍​ facility to understand what caused inaccurate results associated with magellan diagnostics’ leadcare tests.  Full Article

C.R. Bard shareholders approve proposed merger with Becton Dickinson
Tuesday, 8 Aug 2017 04:54pm EDT 

Aug 8 (Reuters) - Becton Dickinson And Co :Bard shareholders approve proposed merger with becton, dickinson.Becton dickinson and co - ‍proposed transaction is presently expected to close in fourth calendar quarter of 2017​.  Full Article

BRIEF-BD board increases dividend

* Becton Dickinson And Co - ‍declared a quarterly dividend of $0.75 per common share, an increase of 2.7 percent from previous quarter​ Source text for Eikon: Further company coverage: